Clinical Trials Directory

Trials / Completed

CompletedNCT00457990

Neurodevelopment After Early Iron Supplementation

Early Versus Late Enteral Iron Supplementation in Infants With a Birth Weight of Less Than 1301g - Neurocognitive Development at 5.3 Years Corrected Age

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
204 (planned)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
4 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Background: Iron deficiency in early childhood may impair neurodevelopment. Aim: To examine whether early iron supplementation improved neurodevelopment in preterm infants. Method: Children who participated in a clinical trial of iron supplementation were invited for a neurodevelopmental follow-up examination at the time of school entry.

Detailed description

Children with a birth weight of \< 1301g who participated in a randomized controlled trial of early versus late enteral iron supplementation were evaluated applying a standardized neurological evaluation, the Kaufmann Assessment Battery for Children, and the Gross Motor Function Classification Scale (GMFCS) at the age of school entry. Severe disability was defined as any of the following: any abnormal neurological examination associated with a severely impaired mobility (GMFCS\>1), severe cognitive impairment (mental processing composite (MPC) \<51), hearing loss requiring amplification, or blindness. The absence of disability was defined as normal neurological examination, normal mobility (GMFCS=0), and normal cognitive development (MPC\>85) and the absence of any severe hearing and visual impairment.

Conditions

Interventions

TypeNameDescription
DRUGOral administration of ferrous sulphate

Timeline

Start date
2002-04-01
Completion
2005-12-01
First posted
2007-04-09
Last updated
2007-04-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00457990. Inclusion in this directory is not an endorsement.